Expression, localization and anti-fibrotic effect of HSPG2 in idiopathic pulmonary fibrosis

Read full text Summarise with VIRAT
Authors: Yuehua Chen, rui lan, Luyao Qin, Chen Xing, Guiping Han
Cited by: 0
References: 11

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by excessive pulmonary tissue fibrosis, and the role of pulmonary epithelial cells in its pathological process has attracted increasing attention. The heparan sulfate proteoglycan 2 (HSPG2, also known as perlecan) gene is involved in the regulation of various cellular functions, but its mechanism of action in IPF remains unclear. This study aimed to systematically investigate the expression characteristics, cellular localization and functional effects of HSPG2 in IPF. Methods Lung tissue samples from 8 clinical IPF patients were collected, and the expression of HSPG2 in epithelial cells was detected by immunohistochemistry and immunofluorescence. A bleomycin-induced mouse model of pulmonary fibrosis was established, and an in vitro fibrosis model was constructed by stimulating human pulmonary epithelial cells (A549, Beas-2b) with transforming growth factor beta 1 (TGF-β1). Results HSPG2 expression was significantly upregulated in lung tissues of IPF patients, lung tissues of fibrotic mice and human pulmonary epithelial cells stimulated with TGF-β1. TGF-β1 could induce the upregulation of fibronectin 1 (FN1) and alpha-smooth muscle actin (α-SMA) in human pulmonary epithelial cells, while HSPG2 silencing effectively inhibited the above effects and attenuated TGF-β1-induced cell proliferation and migration. Conclusions HSPG2 is highly expressed during pulmonary fibrosis, and its silencing can inhibit fibrotic activation, proliferation and migration of epithelial cells, suggesting that HSPG2 may play an important profibrotic role in IPF.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary Hypertension Research and Treatments TGF-β signaling in diseases

Publication details

Journal / source
Research Square
Publication date
25 March 2026
Language
EN
Document type
Preprint